rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Olivier Samuel

Director

Company insider

Files Form 4 as: Director, NewcelX.

In numbers

Trades disclosed
4
Buys
1
Sells
0
Bought
$450K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
27 Apr 2026
Last trade
27 Apr 2026
Last filed
29 Apr 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
NCEL NewcelXDirector · Biotechnology · last 27 Apr 20261 buy · 0 sells

Activity over time

1 Apr – 1 Oct
01Apr 26Jun 26Jul 26Sep 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
27 Apr 2026filed 29 Apr 2026NCEL NewcelXBiotechnologySEC FORM 4 Bought$225K81,818 at $2.75filing
27 Apr 2026filed 29 Apr 2026NCEL NewcelXoption or derivative · BiotechnologySEC FORM 4 Code P—114,545filing
27 Apr 2026filed 29 Apr 2026NCEL NewcelXoption or derivative · BiotechnologySEC FORM 4 Code P—114,545filing
27 Apr 2026filed 29 Apr 2026NCEL NewcelXBiotechnologySEC FORM 4 Bought$225K81,818 at $2.75filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Michel RevelCSO and Director · CSO and Director at NewcelX, filing Form 4 there in the last year